View Press Releases
-
Greenphire Demonstrates Continued Commitment to Global Sponsors and Sites; Participates in Two Leading European Clinical Trial Conferences and Hosts User Group in Poland
KING OF PRUSSIA, PA, UNITED STATES - Nov 18, 2019 - Greenphire, the global leader in financial workflow automation solutions for clinical trials, today announced its company executives will present at two of Europe's most important clinical trial conferences, the Central & Eastern European Site Symposium in Warsaw, Poland on Monday, November 18 and Clinical Trials Europe, in Barcelona, Spain on Thursday, November 21
Nov 18, 2019
-
Life Image and Graticule Launch GLIMPS in the New AWS Data Exchange
NEWTON, MA, UNITED STATES - Nov 18, 2019 - Life Image, one of the worlds largest medical evidence networks for clinical and imaging data, and its strategic partner, Graticule, an advanced real world data firm, announced the availability of GLIMPS (Graticule Life Image Machine Parsed Set) data licensing subscriptions in AWS Data Exchange, a new service that makes it easy for millions of Amazon Web Services (AWS) customers to securely find, subscribe to, and use third-party data in the cloud
Nov 18, 2019
-
Montrium Releases Office 365 Compliance Toolkits to Accelerate Transition to Cloud for the Life Sciences
MONTREAL, QC, CANADA - Nov 20, 2019 - Montrium, an experienced and trusted technology consulting company for the life sciences industry, today announced the launch of a series of comprehensive service Toolkits to support migrating and managing regulated content in Microsofts Office 365 platform
Nov 18, 2019
-
Survey Findings Show Increase in Clinical Trial Results Transparency
JERSEY CITY, NJ, UNITED STATES - Nov 15, 2019 - TrialScope, the global leader in clinical trial transparency and disclosure compliance solutions, has released results from its 2nd Biennial Plain Language Summaries (PLS) Survey
Nov 15, 2019
-
Lifebit and Medley Genomics Partner to Deliver Streamlined Solution Supporting New Diagnostic and Therapeutic Discoveries
LONDON, UK - Nov 14, 2019 -
Nov 14, 2019
Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, and Medley Genomics, a company focused on using advanced data analytics to support better diagnosis and treatment of complex diseases, announced today their partnership agreement
-
Creative Diagnostics Introduces New Foodborne Pathogen Antibodies and Antigens
SHIRLEY, NY, UNITED STATES - Nov 14, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics launches a large range of foodborne pathogen antibodies and antigens, which have been validated to work in various types of immunoassays and can be supplied as high quality tools for the detection of foodborne pathogens
Nov 13, 2019
-
MeMed Wins €2.5M Award from European Innovation Council
HAIFA, ISRAEL - Nov 13, 2019 - MeMed Ltd., a leader in host response-based diagnostic solutions, today announced that it has received €2
Nov 13, 2019
-
Baystate Health and Life Image Announce Strategic Partnership to Develop AI Innovations to Improve Treatment Decisions and Match Cancer Patients to Clinical Trials
BOSTON & SPRINGFIELD, MA, UNITED STATES - Nov 12, 2019 - Baystate Health, the premier integrated health system serving more than 800,000 patients in western New England, announced a strategic partnership with Life Image, the largest medical evidence network providing access to points of care and curated clinical and imaging data, to develop novel artificial intelligence tools that would help advance technical innovations in radiology, neurology and oncology
Nov 13, 2019
-
LG Chem Life Sciences Expands Partnership with Avacta Group plc
CAMBRIDGE, UK, UNITED KINGDOM - Nov 13, 2019 - Avacta Group plc (AIM:AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to provide an update on the Affimer therapeutics development partnership and license agreement with LG Chem Life Sciences (LG Chem), part of the South Korean LG Group, to develop Affimer therapeutics in several disease areas
Nov 13, 2019
-
Turbine secures €3 million EUR seed fund to expand the potential of simulation-first drug discovery
LONDON, UK & BUDAPEST, HUNGARY - Nov 13, 2019 - Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin Ventures
Nov 13, 2019
-
X4 Pharmaceuticals Receives Breakthrough Therapy Designation from the FDA for Mavorixafor for the Treatment of WHIM Syndrome
CAMBRIDGE, MA, UNITED STATES - Nov 12, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced that the U
Nov 12, 2019
-
Lifebit Announces General Release of its Federated Genomics Cloud Operating System
LONDON, UK - Nov 7, 2019 - Lifebit Biotech, a leading innovator in bioinformatics and cognitive software solutions, announced today the general release of Lifebit CloudOS
Nov 8, 2019
-
UKI2S wins Best Sector Support Organisation at the OBN Awards
LONDON, UK - Nov 8, 2019 - UK Innovation & Science Seed Fund (UKI2S) is delighted to announce it is has been awarded Best Sector Support Organisation at the 11th Annual OBN Awards celebration last night
Nov 8, 2019
-
Signant Health Host 8th Annual eCOA Forum To Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology
PHILADELPHIA, PA - Nov 7, 2019 - Signant Health is proud to host its 8th annual eCOA Forum, which convenes clinical operations and outcomes research leaders for the industry’s premier event focused on eCOA, eConsent, and patient-centric technology
Nov 7, 2019
-
Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer’s in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure.
PHILADELPHIA, PA - Nov 7, 2019 - Signant Health, formerly CRF Health and Bracket, announced today that it is sponsoring the Philadelphia Walk to End Alzheimers
Nov 7, 2019
-
X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor for the Treatment of Severe Congenital Neutropenia
CAMBRIDGE, MA, UNITED STATES - Nov 5, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of a Phase 1b clinical trial of mavorixafor (X4P-001) for the treatment of Severe Congenital Neutropenia (SCN), a group of rare blood disorders characterized by abnormally low levels of neutrophils
Nov 5, 2019
-
Microway Showcases NVIDIA® DGX-2™ AI System at GTC DC 2019
PLYMOUTH, MA, UNITED STATES - Nov 4, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for HPC and AI, announces the NVIDIA® DGX-2 system will be showcased in Microways booth at the GPU Technology Conference 2019, November 4th – 6th in Washington, D
Nov 4, 2019
-
LetsGetChecked Appoints Leading Healthcare Innovator Sasha Khursheed Said as Senior Vice President of Revenue
NEW YORK, NY, UNITED STATES - Nov 5, 2019 - New York - LetsGetChecked, a leading direct-to-consumer at-home health testing company, today announced the appointment of Sasha Khursheed Said as Senior Vice President of Revenue
Nov 4, 2019
-
BetterPT and PromptEMR Partner to Provide Industry-First, End-to-End Management Solution for Physical Therapy Practices
NEW YORK, NY, UNITED STATES - Oct 29, 2019 - New York – October 29, 2019 - BetterPT, an integrated healthcare technology platform company providing end-to-end digital connectivity between physical therapists (PT), patients, and physicians, and PromptEMR, a fully integrated enterprise solution to manage outpatient PT clinics, today announced a partnership to launch a first of its kind, turnkey business management system for PT clinics
Nov 4, 2019
-
LetsGetChecked Appoints Healthcare Industry Veteran Troy Cox to Board of Directors
NEW YORK, NY, UNITED STATES - Nov 4, 2019 - New York- LetsGetChecked, a leading direct-to-consumer at-home health testing company, today announced the appointment of Troy Cox to its Board of Directors
Nov 4, 2019